Individuals with underlying inflammation present with a high prevalence of non-specific co-morbid symptoms including sleep disturbance and fatigue. However, the association between cellular expression of proinflammatory cytokines, alterations of sleep depth and daytime fatigue has not been concurrently examined. In healthy adults (24-61 years old), evening levels of monocyte intracellular proinflammatory cytokine production were assessed prior to evaluation of polysomnographic sleep and measures of fatigue the following day. Stimulated monocyte production of interleukin-6 (IL-6), but not tumor necrosis factor a (TNF-a), was negatively associated with slow wave sleep (DR 2 = .17, p = .029). In contrast, stimulated monocyte production of IL-6 was positively associated with rapid-eye movement (REM) sleep duration during the first sleep cycle (DR 2 = .26, p < .01). Moreover, evening stimulated production of IL-6 was associated with fatigue the following day (DR 2 = .17, p = .05). Mediation analyses showed that slow wave sleep, but not REM sleep duration, mediated the relationship between evening levels of IL-6 production and daytime fatigue. These results indicate that increases in stimulated monocyte production of IL-6 may be associated with decreases in slow wave sleep and increases in REM sleep duration. Relative loss of slow wave sleep may be one pathway through which cellular inflammation leads to daytime fatigue.
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Introduction
Sleep disturbance is a common problem, affecting approximately one third of Americans. Research suggests that individuals who report some form of sleep disturbance may be at greater risk for a number of medical problems, including obesity, diabetes, heart disease, and depression (LeBlanc et al., 2007; Ohayon, 2005 Ohayon, , 2008 Spiegel, 2008; Van Cauter et al., 2008) . In addition, a number of studies have demonstrated that sleep problems take a major toll on health related quality of life, in which inadequate sleep is associated with worse self-reported general health, fatigue, and less vitality (Lee et al., 2009; Winkelman et al., 2009) . Likewise, population based studies have shown that individuals with sleep problems have more physical health complaints and are more likely to miss work in the past 30 days (Bolge et al., 2009; Stein et al., 2008) . Further, sleep disturbance is related to reduced quality of life across several dimensions, including declines in mental health, fatigue, and impairments in both physical and social functioning (Bolge et al., 2009 (Bolge et al., , 2003 LeBlanc et al., 2007) .
Proinflammatory cytokines are associated with a cluster of behavioral symptoms known as sickness behaviors. These symptoms, which include fatigue, sleep disturbance, depression, loss of appetite, and inability to concentrate (Dantzer, 2001 (Dantzer, , 2009 , are common in individuals with medical conditions involving underlying inflammation (Collado-Hidalgo et al., 2008a; Lorton et al., 2008; Myers, 2008; Wood et al., 2006) . Additionally, recent findings from population based studies reveal that markers of inflammation are associated with fatigue or reductions in vitality (Cho et al., 2009; Raison et al., 2009) , and poor health related quality of life (Raison et al., 2009) . Moreover, increases of the inflammatory marker, C-reactive protein (CRP), prospectively predict fatigue in community-dwelling adults (Cho et al., 2009 ). Taken together, these findings suggest that inflammation and alterations in sleep may contribute to fatigue and/or reductions in vitality.
Inflammation is thought to induce disturbances of sleep via alterations in the sleep cycle as defined by changes in sleep architecture. Indeed, prior studies have found that increases in circulating levels of IL-6 correlate with decreases of slow wave sleep (SWS) (Burgos et al., 2006; Hong et al., 2005) , as well as increases in the amount and percentage of rapid-eye movement (REM) sleep (Irwin et al., 2004) and REM sleep density (Motivala et al., 2005) . In addition, stimulated production of IL-6 in mixed cell cultures is associated with increases in REM sleep amounts and percentage (Redwine et al., 2003) . Moreover, in alcohol dependent persons who have high amounts of REM sleep, administration of a proinflammatory cytokine antagonist partially normalizes amounts of
